It could also activate the peroxisome proliferator-activated receptor (PPAR) and adiponectin expression and decrease the liver X receptors (LXR)-α level (52, 53) to treat adiposity and atherosclerosis. This evidence concerns the gene ADIPOQ and atherosclerosis.